Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Oura seeks to raise up to $2.2B in IPO

    22. September 2026

    Ascend Learning Acquires AI Scheduling Platform M7 Health

    22. September 2026

    Agentic AI in MedTech: Driving efficiency and care outcomes

    21. September 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Oura seeks to raise up to $2.2B in IPO
    News

    Oura seeks to raise up to $2.2B in IPO

    HealthradarBy Healthradar22. September 2026Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Oura seeks to raise up to .2B in IPO
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Dive Brief:

    • Wearables firm Oura is seeking up to $2.2 billion in an initial public offering, the company disclosed in a Monday securities filing. 
    • While the IPO has not been priced yet, Oura estimates its shares will be valued at $40 to $44 each. Oura plans to offer 13.5 million shares of common stock, and selling stockholders plan to offer 36.5 million shares, for a total of 50 million shares.
    • Oura is going public as wearables firms grapple with the line between wellness features and medical devices. Oura currently faces a proposed class action lawsuit over the accuracy of its sleep tracking features.

    Dive Insight:

    Oura makes smart rings that track activity, sleep, stress and other metrics. Currently, none of Oura’s features have been cleared by the Food and Drug Administration as a medical device, as they fall under the agency’s wellness exemption.

    However, as makers of the technology look to stand apart from the competition, wearables companies are inching closer to the FDA regulated domain. Oura has said it plans to offer a tool to track nighttime blood pressure trends, which would be considered a wellness feature by the FDA. Separately, the company is working on a study of a feature to surface hidden hypertension risk, which would need to go through the regulator. 

    Oura has recently added other health features, including letting people upload results from bloodwork. The company has also partnered with Dexcom, which makes continuous glucose monitors, and Resmed, which makes devices to treat sleep apnea and other respiratory conditions. 

    In its filing, Oura cautioned that there is no guarantee the FDA will determine its features to be exempt from device regulations, and that the agency’s general wellness guidance could change in the future, narrowing the scope of products available for enforcement discretion.

    Earlier this year, the FDA changed its wellness guidance without any prior announcement, allowing wearables that measure blood pressure to fall under the wellness exemption if they meet certain requirements. 

    Oura’s revenue is growing, according to the filing, stemming from sales of its devices and corresponding memberships. The company plans to trade on Nasdaq under the ticker “OURA.”



    Source link

    2.2B IPO Oura Raise seeks
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleAscend Learning Acquires AI Scheduling Platform M7 Health
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Ascend Learning Acquires AI Scheduling Platform M7 Health

    22. September 2026
    News

    Agentic AI in MedTech: Driving efficiency and care outcomes

    21. September 2026
    News

    Mayo Clinic, Thermo Fisher partner to create Precure

    21. September 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 2025772 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 2025746 Views

    Luna ring review | TechRadar

    26. Dezember 2025188 Views

    Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B

    20. Februar 2026165 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Marvel’s Dyasonic: A Superhero Powered by Sound—and Diabetes Tech

    13. Juni 2025772 Views

    Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia –

    19. Juni 2025746 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.